BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34689087)

  • 1. Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
    Le HH; Cinaroglu SS; Manalo EC; Ors A; Gomes MM; Duan Sahbaz B; Bonic K; Origel Marmolejo CA; Quentel A; Plaut JS; Kawashima TE; Ozdemir ES; Malhotra SV; Ahiska Y; Sezerman U; Bayram Akcapinar G; Saldivar JC; Timucin E; Fischer JM
    EBioMedicine; 2021 Nov; 73():103646. PubMed ID: 34689087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics procedure for investigating senolytic (anti-aging) agents: A digital signal processing technique.
    Nwankwo N; Okafor I
    Aging Med (Milton); 2023 Dec; 6(4):338-346. PubMed ID: 38239718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.
    Baar MP; Brandt RMC; Putavet DA; Klein JDD; Derks KWJ; Bourgeois BRM; Stryeck S; Rijksen Y; van Willigenburg H; Feijtel DA; van der Pluijm I; Essers J; van Cappellen WA; van IJcken WF; Houtsmuller AB; Pothof J; de Bruin RWF; Madl T; Hoeijmakers JHJ; Campisi J; de Keizer PLJ
    Cell; 2017 Mar; 169(1):132-147.e16. PubMed ID: 28340339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel senolytic by precise disruption of FOXO4-p53 complex.
    Tripathi U; Chaib S; Gerdes EOW; Hogan KA; Zhu Y
    EBioMedicine; 2021 Dec; 74():103693. PubMed ID: 34768086
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs.
    Chang M; Gao F; Gnawali G; Xu H; Dong Y; Meng X; Li W; Wang Z; Lopez B; Carew JS; Nawrocki ST; Lu J; Zhang QY; Wang W
    J Med Chem; 2024 May; 67(9):7301-7311. PubMed ID: 38635879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice.
    Zhang C; Xie Y; Chen H; Lv L; Yao J; Zhang M; Xia K; Feng X; Li Y; Liang X; Sun X; Deng C; Liu G
    Aging (Albany NY); 2020 Jan; 12(2):1272-1284. PubMed ID: 31959736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Strategies for the Detection and Elimination of Senescent Cells.
    García-Fleitas J; García-Fernández A; Martí-Centelles V; Sancenón F; Bernardos A; Martínez-Máñez R
    Acc Chem Res; 2024 May; 57(9):1238-1253. PubMed ID: 38604701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.
    González-Gualda E; Pàez-Ribes M; Lozano-Torres B; Macias D; Wilson JR; González-López C; Ou HL; Mirón-Barroso S; Zhang Z; Lérida-Viso A; Blandez JF; Bernardos A; Sancenón F; Rovira M; Fruk L; Martins CP; Serrano M; Doherty GJ; Martínez-Máñez R; Muñoz-Espín D
    Aging Cell; 2020 Apr; 19(4):e13142. PubMed ID: 32233024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cellular senescence via the FOXO4-p53 axis.
    Bourgeois B; Madl T
    FEBS Lett; 2018 Jun; 592(12):2083-2097. PubMed ID: 29683489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs.
    L'Hôte V; Mann C; Thuret JY
    Open Biol; 2022 Sep; 12(9):220171. PubMed ID: 36128715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovering small-molecule senolytics with deep neural networks.
    Wong F; Omori S; Donghia NM; Zheng EJ; Collins JJ
    Nat Aging; 2023 Jun; 3(6):734-750. PubMed ID: 37142829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker.
    Poblocka M; Bassey AL; Smith VM; Falcicchio M; Manso AS; Althubiti M; Sheng X; Kyle A; Barber R; Frigerio M; Macip S
    Sci Rep; 2021 Oct; 11(1):20358. PubMed ID: 34645909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
    Born E; Lipskaia L; Breau M; Houssaini A; Beaulieu D; Marcos E; Pierre R; Do Cruzeiro M; Lefevre M; Derumeaux G; Bulavin DV; Delcroix M; Quarck R; Reen V; Gil J; Bernard D; Flaman JM; Adnot S; Abid S
    Circulation; 2023 Feb; 147(8):650-666. PubMed ID: 36515093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic.
    Al-Mansour F; Alraddadi A; He B; Saleh A; Poblocka M; Alzahrani W; Cowley S; Macip S
    Aging (Albany NY); 2023 Mar; 15(7):2373-2394. PubMed ID: 36988504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
    Shahbandi A; Rao SG; Anderson AY; Frey WD; Olayiwola JO; Ungerleider NA; Jackson JG
    Cell Death Differ; 2020 Nov; 27(11):3097-3116. PubMed ID: 32457483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.
    Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S
    Elife; 2022 May; 11():. PubMed ID: 35507395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecular Senolytics via Intracellular Oligomerization of Peptides in Response to Elevated Reactive Oxygen Species Levels in Aging Cells.
    Kim S; Chae JB; Kim D; Park CW; Sim Y; Lee H; Park G; Lee J; Hong S; Jana B; Kim C; Chung H; Ryu JH
    J Am Chem Soc; 2023 Oct; 145(40):21991-22008. PubMed ID: 37664981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53.
    Kim J; Ahn D; Park CJ
    FEBS J; 2022 Jun; 289(11):3163-3182. PubMed ID: 34954873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
    Xing X; Tang Q; Zou J; Huang H; Yang J; Gao X; Xu X; Ma S; Li M; Liang C; Tan L; Liao L; Tian W
    Acta Biomater; 2023 Feb; 157():352-366. PubMed ID: 36470392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Senolytics in Cardiovascular Disease.
    Dookun E; Passos JF; Arthur HM; Richardson GD
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.